Rating History for Momenta Pharmaceuticals (MNTA) by H.C. Wainwright
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/25/2020 | Douglas Tsao | Downgrade | Neutral (Buy) |
N/A (N/A) |
52.15 (52.48) |
0.63% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/25/2020 | Douglas Tsao | Downgrade | Neutral (Buy) |
N/A (N/A) |
52.15 (52.48) |
0.63% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||